Failure of the immune system to clear parasites may lead to prolonged disease or exacerbated pathology. One reason for this failure may lie in the immunomodulatory effects induced by parasites, which then favor the expansion of regulatory T cells (Tregs). Tregs are actively involved in the control of pathological and physiological immune responses, thereby contributing to the maintenance of immunological self-tolerance and immune homeostasis (1-3). Regulatory single nucleotide polymorphism (SNPs) can cause significant changes in gene expression in functional immune genes. Promoter regions are potential candidates for the presence of such functional SNPs, as they are involved in transcription initiation and many of the cis-acting elements that regulate gene expression possibly harbor functional polymorphisms (4) . Investigation of these human polymorphisms in the promoter region of immune genes possibly reflects the level of susceptibility to parasitic infection and of Treg expression. We investigated the tumor necrosis factor receptor superfamily member 18 (TNFRSF18) locus, a 228-amino acid type I transmembrane protein known to play a key role in the regulation of T cell receptor-mediated cell death (5). In the current study, the occurrence of different promoter variants inducing differential expression of TNFRSF18 was validated using transient transfection assays.
Material and Methods
Forty DNA samples obtained from unrelated Gabonese individuals were screened for SNPs in the promoter region of the TNFRSF18 by the polymerase chain reaction (PCR) and subsequent sequencing. The study was approved by the local Ethics Committee of the International Foundation of the Albert Schweitzer Hospital. Fragments of the promoter of the TNFRSF18 genes were amplified using the primer pairs -TNFRSF18-forward: 5'-GCGCCTCTTTCT ATCCAGG-3', TNFRSF18-Intern01: 5'-GGCTCCTCC TCAACTCCCTCC-3', and with TNFRSF18-reverse: chip.org/). The respective genomic DNA identified to have SNPs was amplified with infusion primers and were cloned to the pGL3 basic vector using the infusion advantage PCR cloning kit (Clontech, USA). Two independent colonies were picked from these transformations and maxi prep was performed using the Endofree plasmid maxi kit (Qiagen).
We tested the activities of the observed polymorphic promoters in unstimulated Jurkat T cell lines. In principle, five independent transfection experiments for each construct were performed in duplicate with Jurkat T cells using the TransIT-Jurkat Transfection Reagent (Mirus Bio Corporation, USA) as recommended by the manufacturer. Data were analyzed by the StatView software (http://www.statview. com). The activity of the TNFRSF18 promoter variants was compared to the activity of the major allele based on their luciferase activities. P values were calculated by ANOVA corrected by the Bonferroni/Dunn test. The differences were considered to be significant when P ≤ 0.05. 
Results
Three SNPs were identified in 40 subjects. Two novel SNPs were identified at position #ss2080581724 (C/T) and #ss2080581728 (C/T) and an SNP that has been described earlier in the SNPper database was identified at position #rs3753344 (C/T). Their respective genotype and allelic frequencies are summarized in Table 1 . All three SNPs observed were heterozygous. Both the novel SNPs were linked to the described SNP #rs3753344 (C/T). Comparison of the activity of all three TNFRSF18 promoter variants based on luciferase activity indicated decreased activity for one variant compared to the Major allele (Figure 1) . The P values were significant for Construct 2 (#ss2080581728/#rs3753344) compared to the major allele (P = 0.015). The P values indicated statistical significance when Construct 1 (#ss2080581724/#rs3753344) was compared to construct 2 (#ss2080581728/#rs3753344; P = 0.002).
Discussion
In the current study, we identified two novel promoter variants in the TNFRSF18 gene locus. A study in the context of regulatory polymorphisms in the TNF receptor superfamily had reported a similar polymorphism (#rs3753344 C/T) with an allele frequency of 10% among 24 Korean individuals (6) and an allele frequency of 20% was observed in Japanese individuals as obtained from the JSNP database (http://www. snp.ims.u-tokyo.ac.jp). The current study revealed that the SNPs (#rs3753344 C/T) contribute to 15% of allelic distribution among 40 Gabonese individuals, in agreement with the allele frequencies of individuals from an Afro-American ethnic background (http://snpper.chip.org). In the Nigerian Yorubas, both alleles occur at a frequency of 0.5 compared to the NCBI HapMap database. It appears that a significant difference in the distribution of SNP allele frequencies occurs among diverse ethnic groups, possibly reflecting the role of these regulatory SNPs in confined infectious challenges. In order to associate any disease severity with any of these newly identified SNPs, a very large cohort of samples is obligatory. The regulatory SNPs identified in the current study will provide useful information for understanding the relevance of sequence polymorphisms in populations of different ethnic background and may serve as a basis to study parasite susceptibility in association studies.
